Pulse Biosciences, Inc Common Stock (DE) Earnings Dividend

Pulse Biosciences, Inc Common Stock (DE)’s revenue jumped +Inf% since last year same period to $0.43Mn in the Q2 2026. On a quarterly growth basis, Pulse Biosciences, Inc Common Stock (DE) has generated 8.23% jump in its revenue since last 3-months.

Pulse Biosciences, Inc Common Stock (DE)’s net profit fell -28.64% since last year same period to $-24.66Mn in the Q2 2026. On a quarterly growth basis, Pulse Biosciences, Inc Common Stock (DE) has generated -32.7% fall in its net profits since last 3-months.

Pulse Biosciences, Inc Common Stock (DE)’s net profit margin jumped NaN% since last year same period to -5681.34% in the Q2 2026. On a quarterly growth basis, Pulse Biosciences, Inc Common Stock (DE) has generated -22.61% fall in its net profit margins since last 3-months.

Pulse Biosciences, Inc Common Stock (DE)’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -12.9% fall from last quarter’s estimates.

Pulse Biosciences, Inc Common Stock (DE)’s earning per share (EPS) estimates for the current year stand at -0.35.

Pulse Biosciences, Inc Common Stock (DE)’s earning per share (EPS) fell -28.57% since last year same period to -0.36 in the Q2 2026. This indicates that the Pulse Biosciences, Inc Common Stock (DE) has generated -28.57% annual rate of fall in its earning per share (EPS) in the last 4 quarters.